Back to discover
Disease

Spastic Paraplegia, Hereditary

Clinical development underwayEmerging research
1
Publications
1
Clinical trials
12
Associated genes
1
Related proteins
2023
Latest publication
Current focus
Therapeutic developmentGenetics & risk factorsDisease mechanisms & pathology
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
0
Late-stage
1
Completed
Recently completed
Phase 2 · Completed · Institut National de la Santé Et de la Recherche Médicale, France

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes3
  • Heredodegenerative Disorders, Nervous System1
  • Mixed Function Oxygenases1
  • Spastic Paraplegia, Hereditary1
Leading journals1
  • Genes1
Leading researchers8
  • Abicht A1
  • Arnold P1
  • German A1
  • Jukic J1
  • Laner A1
  • Mennecke A1
  • Regensburger M1
  • Schmidt MA1
Affiliations (unnormalised)4
  • Center for Rare Diseases (ZSEER)1
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)1
  • Institute of Functional and Clinical Anatomy1
  • Institute of Neuroradiology1

Associated genes

12 matches

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

Disease biology

1 match

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. (J Neurol Neurosurg Psychiatry 1998 Jan;64(1):61-6; Curr Opin Neurol 1997 Aug;10(4):313-8)

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.